Vaccines

19 Jan 2010 Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-cell Vaccines Against House Dust Mite and Cat Allergies
19 Jan 2010 Mymetics Corporation: The First Human Vaccinations of Mymetics' Preventative HIV Vaccine Candidate are Well Tolerated
15 Jan 2010 International Medica Foundation Reaches Final Vaccination Milestone in Phase II Clinical Trial for Rotavirus Vaccine
13 Jan 2010 Start of Phase II Study for Intranasal, Seasonal Influenza Vaccine deltaFLU AVIR Green Hills Biotechnology AG
13 Jan 2010 Xcellerex Initiates Phase I Clinical Trial of Novel Yellow Fever Vaccine
12 Jan 2010 NOVAVAX Announces Positive Preclinical Results for its Respiratory Syncytial Virus (RSV) Vaccine Candidate
11 Jan 2010 Inhibitex Provides Update on Its Staph Vaccine, FV-100 and INX-189 Development Programs
07 Jan 2010 Mechanism of Action for Vical's Vaxfectin(R) Adjuvant Expands Potential Applications
07 Jan 2010 Hawaii Biotech Completes Dosing of Phase 1 Trial for Dengue Virus Monovalent Vaccine
04 Jan 2010 Intercell starts an additional efficacy trial for its patch-based investigational Travelers’ Diarrhea Vaccine System in Asia
30 Dec 2009 Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine
29 Dec 2009 Fifteen Percent of ADXS11-001 Treated Cervix Cancer Patients Still Alive Three Years after Initial Dosing
29 Dec 2009 Vical Confirms Advantages of DNA Technology Platform With Vaccine for H1N1 Influenza
28 Dec 2009 Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
28 Dec 2009 Vical's Allovectin-7(R) Phase 3 Trial Receives Positive Review From Safety Monitoring Board
28 Dec 2009 Intercell announces initiation in the U.S. of a Phase III study for vaccine to protect children against Japanese Encephalitis
21 Dec 2009 All three Novartis A(H1N1) 2009 influenza vaccines prequalified by World Health Organization (WHO) for use in developing world
21 Dec 2009 Medicago reports positive Phase I results for its avian flu pandemic vaccine
18 Dec 2009 Novartis meningococcal vaccine Menveo® recommended for approval in the European Union for prevention of disease in adolescents and adults
16 Dec 2009 Intercell provides update on ongoing Phase II vaccine studies
16 Dec 2009 Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections
15 Dec 2009 Sanofi Pasteur expands study of vaccine against Clostridium difficile into the U.S.
14 Dec 2009 Pfizer Receives European Authorization For Prevenar 13* For The Prevention Of Pneumococcal Disease In Infants And Young Children
14 Dec 2009 Generex Presents Encouraging Interim Results of Phase II Breast Cancer Study
11 Dec 2009 GSK and Intercell form strategic alliance to develop and commercialise innovative needle-free patch-based vaccines

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top